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Thrombin-activated protease-activated receptor (PAR)-1 regulates the proliferation of neural cells
following brain injury. To elucidate the involvement of PAR-1 in the neurogenesis that occurs in the adult
hippocampus, we examined whether PAR-1 regulated the proliferation of neural stem/progenitor cells
(NPCs) derived from the murine hippocampal dentate gyrus. NPC cultures expressed PAR-1 protein and
mRNA encoding all subtypes of PAR. Direct exposure of the cells to thrombin dramatically attenuated the
cell proliferation without causing cell damage. This thrombin-induced attenuation was almost
completely abolished by the PAR antagonist RWJ 56110, as well as by dabigatran and 4-(2-aminoethyl)
benzenesulfonyl ﬂuoride (AEBSF), which are selective and non-selective thrombin inhibitors, respec-
tively. Expectedly, the PAR-1 agonist peptide (AP) SFLLR-NH2 also attenuated the cell proliferation. The
cell proliferation was not affected by the PAR-1 negative control peptide RLLFT-NH2, which is an inactive
peptide for PAR-1. Independently, we determined the effect of in vivo treatment with AEBSF or AP on
hippocampal neurogenesis in the adult mouse. The administration of AEBSF, but not that of AP, signif-
icantly increased the number of newly-generated cells in the hippocampal subgranular zone. These data
suggest that PAR-1 negatively regulated adult neurogenesis in the hippocampus by inhibiting the pro-
liferative activity of the NPCs.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
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d/4.0/).subgranular zone of the hippocampal dentate gyrus, in order to
maintain the neurogenic potential in the brain (1,2). For neuro-
genesis, neural stem/progenitor cells (NPCs) go through a process of
proliferation, migration, differentiation, survival, and integration,
thereby becoming productive members of the existing circuitry in
the brain. Under normal physiological conditions in the adult, NPCs
predominantly produce neuronal cells in the olfactory bulb in the
case of NPCs derived from the subventricular zone and those in the
dentate gyrus in the case of NPCs derived from the subgranular
zone. The self-renewal of NPCs is regulated by a dynamic interplay
between cell-intrinsic signals and cell-extrinsic signals from the
microenvironment in which the NPCs reside (3). A good under-
standing of the regulation of NPC proliferation would aid the
development of therapeutic strategies for neurological disorders.
Thrombin, a serine protease generated by the cleavage of pro-
thrombin, is an essential component of the coagulation cascade.
Accumulating evidence demonstrates that thrombin physiologi-
cally functions in the central nervous system, with its action being
mediated by a family of protease-activated receptors (PARs, 4). PARsnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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PAR-1, PAR-2, PAR-3, and PAR-4, which are activated by proteolytic
cleavage of their amino terminus by serine proteases such as
thrombin, plasmin, and trypsin. This cleavage reveals a new amino
terminus that acts as a tethered ligand to activate the receptor. Of
the subtypes of PARs, PAR-1, PAR-3, and PAR-4 are activated by
thrombin, whereas PAR-2 is activated by trypsin or tryptase. PARs
couple to multiple Ga proteins (G12/13, Gq/11, and Gi) and their
associated signaling cascades (5).
Thrombin is known to enhance the synthesis and secretion of
nerve growth factor in glial cells and to stimulate astrocyte prolif-
eration through activation of PAR-1 (6). To date, however, there has
been no evidence for the involvement of PARs in the proliferation of
hippocampal NPCs, which contribute to adult neurogenesis in the
hippocampal dentate gyrus. The aim of the present study was to
evaluate the contribution of PAR-1 to the proliferative activity of
NPCs in the mammalian brain. To this end, we examined the effects
of thrombin and PAR-1-related peptides on the proliferation of
NPCs derived from the dentate gyrus of the adult mouse. In addi-
tion to performing in vitro experiments, we also determined the
effect of i.c.v. administration of a thrombin inhibitor and PAR-1
agonist peptide (AP) on hippocampal neurogenesis in the adult
mouse brain.
2. Materials and methods
2.1. Materials
Epidermal growth factor and basic ﬁbroblast growth factor were
obtained from Peprotech (Rocky Hill, NJ, USA). 3-[4,5-
Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT),
penicillin, and streptomycin came fromNacalai Tesque, Inc. (Kyoto).
Neurobasal A medium, 10 PBS, B27 supplement, Glutamax, and
lamininwere purchased from Life Technologies, Gibco (Eugene, OR,
USA). Thrombin (T7513), 4-(2-aminoethyl)benzenesulfonyl ﬂuoride
(AEBSF), and poly-L-ornithine were from SigmaeAldrich Co. (St.
Louis, MO, USA). The following antibodies were used as primary
antibody: rat monoclonal antibody against BrdU (Abcam, Ltd.,
Cambridge, MA, UK); mouse monoclonal antibodies against nestin
(Abcam, Ltd., Cambridge, MA, UK), lipid-binding protein/fatty acid-
binding protein 7 (BLBP, MyBioSource Inc., San Diego, CA, USA), and
microtubule-associated protein 2 (MAP2, Chemicon, Temecula,
CA); rabbit polyclonal antibodies against Prox1 (Chemicon, Teme-
cula, CA), nestin (SigmaeAldrich Co., St. Louis, MO, USA), and
thrombin receptor (H-111, Santa Cruz Biotechnology, Santa Cruz,
CA, USA), which labels PAR-1 (7). Antibodies used as secondary
antibody were Alexa-Fluor 594-conjugated anti-rat IgG (HþL)
antibody, Alexa-Fluor 488-conjugated anti-rabbit IgG (HþL) anti-
body, Alexa-Fluor 488-conjugated anti-mouse IgG (HþL) antibody,
and Alexa-Fluor 568-conjugated anti-mouse IgG (HþL) antibody
(Life Technologies, Molecular Probes, Eugene, OR, USA). Other
chemicals used were the following: 5-bromo-20-deoxyuridine
(BrdU, Roche Diagnostics, Basel, Switzerland), dabigatran (AdooQ
BioScience, Irvine, CA, USA), RWJ 56110 (Tocris Bioscience, Bristol,
UK), Percoll (GE Healthcare, UK Ltd., Buckinghamshire, UK), AP
(SFLLR-NH2, AnaSpec Inc., Fremont, CA, USA), and PAR-1 negative
control peptide (NCP, RLLFT-NH2, Abgent, Inc., San Diego, CA, USA).
These chemicals and all others used were of the highest purity
commercially available.
2.2. Animals
The protocol used heremet the guidelines of the Japanese Society
forPharmacologyandwasapprovedby theCommittee forEthicalUse
of Experimental Animals at Setsunan University. All efforts weremade tominimize animal suffering, to reduce the number of animals
used, and to utilize alternatives to experimental techniques. Adult
male Std-ddY mice weighing 26e28 g at 5e7 weeks of age were
housed in metallic breeding cages in a lighted room and given free
access to food and water for at least 4 days before use.
2.3. Culture of NPCs, proliferation assay, and cell differentiation
Cultures of NPCs were prepared from the hippocampal dentate
gyrus of mice as originally described by Babu et al. (8) with several
modiﬁcations (9). In brief, the hippocampal dentate gyrus was
dissected from 5 mice under microscopic observation (10). Frag-
ments of the tissues were suspended in 3 mL of Neurobasal A
medium by pipetting and thereafter centrifuging them at 200 g
for 5 min. The pellets obtained were suspended in 4 mL of Neu-
robasal A medium containing 2 mg/mL papain, 0.5 mg/mL DNase,
and 0.18 mg/mL neutral protease; and the suspension was then
incubated at 37 C for 4 min. The cell suspensions were mixed with
an equal volume of Neurobasal A medium and then centrifuged at
200g for 5 min. The pellets obtained were suspended in 5.0 mL of
Percoll buffer solution consisting of Neurobasal A medium (3.9 mL),
Percoll (0.99 mL), and 10 PBS (0.11 mL) and centrifuged at 400 g
for 15 min. The pellets were subsequently washed 3 times with
4 mL of Neurobasal A medium each time. Finally, the cells were
suspended in 2 mL of growth medium consisting of Neurobasal A
medium containing B27 supplement, 2 mM Glutamax, 100 U/mL
penicillin, 0.1 mg/mL streptomycin, 20 ng/mL basic ﬁbroblast
growth factor, and 20 ng/mL epidermal growth factor. The surfaces
of 6-well culture dishes were pre-coated at 37 C for 2 h with
coating solution containing 15 mg/mL poly-L-ornithine and 5 mg/mL
laminin, after which the cells were seeded onto them at a density of
1  105 viable cells/mL after counting the number of viable cells.
The cells were then cultured for 24 h in the growth medium, which
was replaced with freshmedium on the next day. Subsequently, the
cultures were maintained by feeding with 75% replacement of the
growth medium every 2 days for 14 days in vitro (DIV) to prepare
primary cultures of NPCs. For preparation of secondary cultures of
NPCs, the primary cultures were harvested, dispersed, replated at a
density of 3  104 cells/mL into 6-well dishes, and incubated for
6e8 DIV. Finally, the secondary cultures were harvested, dispersed,
and then replated at a density of 3 104 cells/mL in 6-well dishes as
tertiary cultures, which were used for the experiments as cultured
NPCs. The cultures were always maintained at 37 C in a 95% (vol/
vol) air/5% (vol/vol) CO2 humidiﬁed incubator.
For proliferation activity, cell viability was determined by using
the MTT assay (11). In addition, proliferative activity was also
assessed in terms of BrdU incorporation into cells during culture. In
brief, cells were exposed to 0.1 mM BrdU for 12 h and then centri-
fuged at 300 g for 10 min. After removal of the medium, the BrdU
level in the cells remaining in the dish was determined by using a
Cell Proliferation ELISA kit according to the manufacturer's in-
structions (Roche Diagnostics, Mannheim, Germany).
For cell differentiation, cells from tertiary cultures were plated at
a density of 2  105 cells/mL onto 15 mg/mL poly-L-ornithine and
5 mg/mL laminin-coated culture dishes and incubated for 24 h in
growth medium. The next day, the growth medium was replaced
with differentiation medium consisting of Neurobasal A medium
containing B27 supplement, 2 mM Glutamax, 100 U/mL penicillin,
0.1 mg/mL streptomycin. After 15 days of culture in vitro the cells
were analyzed immunohistochemically.
2.4. Cytotoxicity assay
To evaluate cell damage, we assayed lactate dehydrogenase
(LDH) activity by using a colorimetric assay (Cytotoxicity LDH assay
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according to the manufacturer's instructions with several modiﬁ-
cations. Cells were seeded at a density of 2  105 cells/mL and
cultured in growthmedium in the presence or absence of thrombin
or AP. The leakage of LDH was expressed as the amount of LDH
released into the medium after a 24-h exposure to thrombin or AP.
Aliquots of the growth medium were transferred to 96-well
microplates, to which Working solution was then added. The
microplate was protected from the light and incubated at room
temperature for 30 min. A microplate reader (Inﬁnite F50, TECAN,
Japan) was used to measure the absorbance at 490 nm.
2.5. Reverse transcriptional-PCR
Total RNA was isolated from the cells or mouse lung with Trizol
by following the manufacturer's instructions. One microgram of
total RNA was reverse transcribed to prepare cDNA by using Oli-
go(dT)15 primer in accordancewith the instructions provided in the
Ready-To-Go You-Prime First-Stranded Beads kit. Aliquots of cDNA
were then ampliﬁed with a 0.4 mMconcentration of each primer set
(Table 1) in 25 mL of reaction mixture containing a 0.2 mM con-
centration of each dNTP, 0.625 units Taq DNA polymerase, 10 mM
TriseHCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, and 0.001% gelatin.
Reactions were carried out for a total of 25e30 cycles with the use
of a Thermal cycler, and then the PCR products were analyzed by
performing 1% agarose gel electrophoresis.
2.6. Immunostaining of cell cultures
The cells were washed with Tris-buffered saline (pH 7.5, TBS)
and thereafter ﬁxed with 4% (wt/vol) paraformaldehyde for 20 min
at 4 C. After having been blocked for 1 h at room temperature with
5% (vol/vol) goat serum in TBS containing 0.03% (wt/vol) Tween 20,
the cells were incubated at 4 C overnight with the primary anti-
body against nestin (1 mg/mL), BLBP (1 mg/mL), PAR-1 (1 mg/mL),
MAP2 (1:500) or Prox1 (1:500). After a wash with 0.03% TBST, they
were then reacted with ﬂuorescence-labeled secondary antibodies
for 2 h at room temperature. Finally, the cells were counterstained
with Hoechst 33342 (5 mg/mL) for 20 min at room temperature.
Stained cells were viewed with a BX41 microscope (Olympus,
Tokyo) equipped with a DS-Ri1 camera (Nikon, Tokyo).
2.7. Drug administration in in vivo experiments
Mice were deeply anesthetized with chloral hydrate (500 mg/
kg, i.p.) and positioned in a stereotaxic apparatus (Narishige, Japan).
Following skin incision, a burr hole corresponding to an i.c.v. in-
jection site was made in the skull with an electrical drill. The
insertion position was determined as follows: Bregma, 0.2 mm;
laterality, 1.0 mm; depth, 2.5 mm. The injection was carried out by
using a syringe-type micro-injection pump (CX07200, ISIS Co., Ltd.,
Osaka) with a 40-gauge needle connected via polyethylene tubingTable 1
Primers used for RT-PCR analysis of mouse PARs.
Genes Upstream (50e30)
Downstream (50e30)
Product (b.p.) Annealing temperature
Annealing time
PAR-1 AGCCAGCCAGAATCAGAGAG
TCGGAGATGAAGGGAGGAG
206 60.1 C
30 s
PAR-2 TGGGAGGTATCACCCTTCTG
CCAGGTTGGCCATGTAAATC
330 62.0 C
30 s
PAR-3 AGACAACTCAGCAAAGCCAAC
TAGCCCTCTGCCTTTTCTTCT
243 57.0 C
30 s
PAR-4 AGCCGAAGTCCTCAGACAAG
GCAAGTGGTAAGCCAGTCGT
303 57.0 C
30 sto a Hamilton syringe and was done at the rate of 0.4 ml/min over a
5-min period.
To label mitotic cells, we gave mice a single injection of BrdU
(50 mg/kg, i.p., dissolved in PBS) immediately after the i.c.v. injec-
tion of drugs. These animals were then returned to their home
cages until the time of decapitation.
2.8. Immunostaining of hippocampal slices
Mice were anesthetized with chloral hydrate (500 mg/kg, i.p.)
and perfused via the heart with PBS, followed by 4% (wt/vol)
paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4). The
brains were quickly removed and further ﬁxed with the same
ﬁxative solution at 4 C overnight. Post-ﬁxed brains were
embedded in parafﬁn, cut into 7 sagittal sections of 3- to 5-mm
thickness at 100-mm intervals in the range from 0.9 to 1.6 mm
relative to lateral (12) with amicrotome, and placed onMatsunami-
adhesive silane-coated glass slides (Matsunami Glass Ind., Kyoto).
The parafﬁn-embedded brain sections were then deparafﬁnized
with xylene, rehydrated by immersion in ethanol of graded
decreasing concentrations of 100% (vol/vol) to 50% (vol/vol), and
ﬁnally washed with water. Sections so obtained were subjected to
the immunohistochemical procedures described below.
Fluoro-Jade-B staining of brain sections was used to identify
degenerating neurons (13). Brieﬂy, coronal sections in 0.06% po-
tassium permanganate were kept on a shaker for 10 min and then
washed in distilled water before immersion in a 0.006% Fluoro-Jade
B (Millipore, Billerica, MA, USA) for 20 min.
For immunostaining of BrdU-positive cells, the sections in
10mM sodium citrate buffer (pH 7.0) were ﬁrst heated for 10min in
a microwave oven. After having been washed with TBST, they were
blocked with 5% normal goat serum for 1 h at room temperature,
and then incubated with the primary antibody against BrdU (3 mg/
mL) at 4 C overnight. After having been washed with TBST, they
were next reacted with the secondary antibody (5 mg/mL Alexia
Fluor 594-conjugated anti-rat IgG) for 2 h at room temperature. The
stained sections were viewed with a BX41 microscope (Olympus,
Tokyo, Japan) having an attached DS-Ri1 camera (Nikon, Tokyo,
Japan), and the total number of highly labeled cells in 7 sections
was counted under the ﬂuorescence microscope and expressed as
the number of positive cells per each animal.
2.9. Data analysis
All data were expressed as the mean ± S.E.M., and the statistical
signiﬁcancewas determined by use of the two-tailed Student t-test,
one-way ANOVAwith Bonferroni/Dunnett post hoc test or two-way
repeated measure ANOVA.
3. Results
3.1. Expression of PARs in NPC cultures
When cells derived from the dentate gyrus of adult mice were
cultured under the present culture conditions, more than 95% of
them were positive for both nestin and BLBP (Fig. 1a), which are
markers of radial glial cells as NPCs in the hippocampus (14,15).
These cells had the ability to differentiate into astroglial cells and
neurons under the culture conditions used for differentiation (data
not shown) and, in addition, showed strong proliferative activity. To
test if the NPC used could differentiate into granule cells during the
culture conditions for differentiation, we performed immuno-
staining of Prox1, which is expressed in granule cells of the hip-
pocampal dentate gyrus throughout embryonic development and
into adulthood (16). Fig. 1b shows that the cells were positive for
Fig. 1. PARs in NPC cultures. (a) NPCs were cultured under the standard conditions described in “Materials and Methods” for immunostaining of nestin (green) and BLBP (red) with
counter staining with Hoechst 33342 (blue). Primary antibodies used: rabbit polyclonal antibody against nestin and mouse monoclonal antibody speciﬁc for BLBP. Secondary
antibodies used: Alexa-Fluor 488-conjugated anti-rabbit IgG antibody and Alexa-Fluor 568-conjugated anti-mouse IgG antibody. (b) NPCs were cultured for 15 days under the
condition for differentiation described in “Materials and Methods” for immunostaining of Prox1 (green) and MAP2 (red). Primary antibodies used: rabbit polyclonal antibody against
Prox1 and mouse monoclonal antibody speciﬁc for MAP2. Secondary antibodies used: Alexa-Fluor 488-conjugated anti-rabbit IgG antibody and Alexa-Fluor 568-conjugated anti-
mouse IgG antibody. Scale bar ¼ 50 mm. These experiments were carried out at least 3e6 times under the same experimental conditions, with similar results each time.
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differentiation, suggesting that the NPC used could indeed differ-
entiate into granule cells.
To determine the expression of PAR subunits in the cells, we
performed immunostaining and reverse transcriptional-PCR anal-
ysis of the cells. Nestin and PAR-1 were co-localized in more than
95% of the cells (Fig. 2a); and reverse transcriptional PCR analysis
revealed that the cells had mRNAs of all 4 PAR subtypes (Fig. 2b).
These data thus suggested that the NPCs prepared actually
expressed all types of PAR.3.2. Effect of thrombin on proliferative activity of NPC cultures
To evaluate the role of PAR-1 in the proliferation of the NPCs, we
next determined the effect of direct exposure of the cells tothrombin on the proliferative activity of the cells. When the cells
were cultured for 4 DIV in the absence of thrombin (in the presence
of vehicle alone) as the control, the number of surviving cells
increased by approximately 4.5-fold over that at 0 DIV. Under the
same experimental conditions, the exposure to thrombin at 1 U/mL
dramatically decreased this number (Fig. 3), indicating that
thrombin signiﬁcantly inhibited the proliferative activity of the
cells.3.3. Effect of thrombin inhibitors and PAR-1 antagonist on
thrombin-induced inhibition of proliferative activity in NPC cultures
Thrombin-induced inhibition of proliferative activity was
partially abolished by singly tested AEBSF and dabigatran, which
are non-selective and selective thrombin inhibitors, respectively
Fig. 2. Expression of PARs in NPC cultures. (a) NPCs were cultured under the standard conditions described in “Materials and Methods” for immunostaining of nestin (red) and
PAR (green) with counter staining with Hoechst 33342 (blue). Primary antibodies used: mouse monoclonal antibody speciﬁc for nestin and rabbit polyclonal antibody against PAR-1.
Secondary antibodies used: Alexa-Fluor 488-conjugated anti-rabbit IgG antibody and Alexa-Fluor 568-conjugated anti-mouse IgG antibody. Scale bar ¼ 50 mm. (b) Total RNA was
isolated from the cells or mouse lung (PC: positive control) and subjected to RT-PCR analysis for detection of PAR-1, PAR-2, PAR-3, and PAR-4 mRNAs by use of their respective
primers described in Table 1. These experiments were carried out at least 6 times under the same experimental conditions, with similar results each time.
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affected the proliferative activity of the cells. In addition to
thrombin inhibitors, the selective PAR-1 antagonist RWJ 56110 had
the ability to abolish the thrombin-induced cell proliferation,
without affecting the proliferative activity of the cells (Fig. 5). These
data suggest that thrombin negatively regulated cell proliferation
through PAR-1 activation caused by proteolytic cleavage of the
amino terminus of PAR-1 in the NPCs.
3.4. Effect of PAR-1-related peptides on proliferative activity of NPC
cultures
Next, we sought to determinewhether the direct exposure to AP
(SFLLR-NH2) would inhibit the proliferative activity of the NPCs.
Expectedly, the exposure for 4 DIV to AP at 100 mM signiﬁcantly
decreased the number of surviving cells in 4-DIV cultures, without
causingmorphological changes or cell death (Fig. 6a and b). The cell
proliferation was not affected by a 4-DIV treatment with NCP
(RLLFT-NH2), which is an inactive peptide for PAR-1 (Fig. 6a and b).
In addition, BrdU incorporation into the cells was also inhibited by
AP, but not by NCP, during the culture period (Fig. 6c), thus sug-
gesting that PAR-1 activation by AP inhibited the proliferative ac-
tivity of the NPCs.
3.5. No damage in NPC cultures exposed to thrombin or AP
Under microscopic observation, thrombin was ineffective in
causing any morphological change in the cells at least after a 4-day
exposure (Fig. 3a). In addition, the results of an LDH release assay
revealed that no signiﬁcant change in the amount of LDH releasedwas observed by a 24-h exposure to AP or thrombin (Fig. 7).
Exposure to thrombin did not signiﬁcantly affect LDH release at
least during culture up to 4 DIV [LDH released (% of control): 1 DIV,
122 ± 6; 2 DIV, 130 ± 8; 3 DIV, 103 ± 5; 4 DIV, 103 ± 12]. These data
suggest that the decrease in proliferative activity induced by
thrombin or AP was not due to damage to the NPCs caused by a
cytotoxic effect of thrombin or AP.3.6. Effect of in vivo treatment with AEBSF or AP on newly-
generated cells in the hippocampal dentate gyrus of the adult mouse
To further evaluate whether thrombin regulated the prolifera-
tion of NPCs in the hippocampal subgranular zone of adult animals,
we determined the effects of AEBSF and AP on the number of BrdU-
incorporating cells in the hippocampal dentate gyrus of adult mice.
Interestingly, the i.c.v. injection of AEBSF signiﬁcantly increased the
number of BrdU-incorporated cells in the hippocampal subgranular
zone, in which NPCs are located for neurogenesis in the adult
hippocampus. Under the same conditions, however, AP treatment
did not signiﬁcantly affect the number of BrdU-labeled cells in the
dentate gyrus (Fig. 8a and b).
Since neuronal damage is known to enhance the proliferation of
the NPCs in the brain (17), we determined whether or not the i.c.v.
injection of either AEBSF or AP had damaged neuronal cells in the
dentate gyrus by staining the cells with Fluoro-Jade B, which is a
high-afﬁnity ﬂuorescent marker that identiﬁes neuronal degener-
ation. Neither AEBSF nor AP caused damage to the neuronal cells in
the dentate gyrus (Fig. 8c). These data showed that AEBSF had the
ability to enhance cell proliferation without causing any neuronal
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Fig. 3. Effect of thrombin on proliferative activity of NPC cultures. Cells were cultured for 4 days in the presence of either vehicle or thrombin (1 U/mL). (a) Typical micrographs
of the cells before the incubation (0 DIV) and after it in either the presence or absence of thrombin (2 bottom photomicrographs). Scale bar ¼ 50 mm. (b) Proliferative activity was
determined before the incubation (0 DIV) or after the incubation for 4 days with either vehicle or thrombin. Values are the mean ± S.E. from 4 independent experiments. *P < 0.05,
signiﬁcantly different from the value obtained for the cultures incubated in the presence of vehicle alone.
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hippocampus.
4. Discussion
The essential importance of our ﬁndings is that the activation of
PAR-1 negatively regulated the proliferation of NPCs in thehippocampal dentate gyrus of naïve adult mice. Evidence for this
proposition came from the current in vitro ﬁndings that both
thrombin and AP had the ability to inhibit cell proliferation of the
cultures of the hippocampal NPCs, inwhich PAR-1 was shown to be
deﬁnitely localized. In addition, the in vivo experiment in the pre-
sent study revealed that an inhibitor of serine proteases including
thrombin was capable of dramatically increasing the number of
Fig. 4. Effect of thrombin inhibitors on thrombin-induced inhibition of prolifer-
ative activity in NPC cultures. Cells were incubated for 10 min with vehicle or AEBSF
(a) or with it or dabigatran (b), and then cultured for 4 days in the presence of either
vehicle or thrombin (1 U/mL). Values are the mean ± S.E. from 4 independent ex-
periments. *P < 0.05, signiﬁcantly different from the value obtained for cultures in the
presence of vehicle alone. #P < 0.05, signiﬁcantly different from the value obtained for
cultures in the presence of thrombin without inhibitor.
Fig. 5. Effect of PAR-1 antagonist on thrombin-induced inhibition of proliferative
activity in NPC cultures. Cells were incubated for 10 min with either vehicle or RWJ
56110, and then cultured for 4 days in the presence of either vehicle or thrombin (1 U/
mL). Values are the mean ± S.E. from 4 independent experiments. *P < 0.05, signiﬁ-
cantly different from the value obtained for cultures in the presence of vehicle alone.
#P < 0.05, signiﬁcantly different from the value obtained for cultures in the presence of
thrombin without the antagonist.
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subgranular zone, which is the location of the NPCs that participate
in neurogenesis in the adult hippocampus. These data support the
idea that thrombin or other serine proteases are endogenously
activated and inhibit the proliferation of NPCs in the hippocampus
under physiological conditions. As further speculation, we suggest
that PAR-1 is constantly activated and thereby negatively regulates
adult neurogenesis in the hippocampus under physiological con-
ditions. Indeed, our current in vivo data suggested that activation of
PAR-1 by AP did not affect the number of newly-generated cells in
the hippocampal subgranular zone. In addition, several lines of
evidence suggest that thrombin exists in the brain parenchyma
under normal physiological conditions and that PAR-1 has roles of
brain functions under physiological conditions, e.g., regulation of
the threshold for synaptic plasticity in the hippocampus (18),
potentiation of NMDA receptor function given the important
contribution to synaptic plasticity and neuronal development (19),
stimulation of neurite retraction (20), and stimulation of astrocyte
proliferation and reversal of stellation (21). Several additional
studies provide support for PAR1 involvement in synaptogenesis
(22) and neuronal development (23). In addition to these ﬁndings,
our current study supposed a novel roles PAR-1 in brain functions
under physiological conditions.Brain injury-activated astrocytes (reactive astrocytes) are
known to be characterized by an abnormal morphology and
excessive proliferation. Of the blood-derived factors that enter the
parenchyma of the brain after brain injury, thrombin plays themost
crucial role, activating astrocytes and producing morphological
changes in them that correlate with their excessive proliferation
(24) through activating PAR-1 in these cells (25). Finally, it was
earlier demonstrated that activation of PAR-1 triggers astrogliosis
after a brain injury (26). Based on these previous ﬁndings and our
current data showing that PAR-1 activation attenuated neuro-
genesis via inhibition of NPC proliferation, we propose that PAR-1
activation following brain injury has the ability to produce up-
regulation of astrogliosis and down-regulation of neurogenesis. In
the damaged hippocampus, however, neurogenesis is known to be
enhanced through increased proliferative activity of NPCs in the
hippocampal subgranular zone and subventricular zone (17). These
ﬁndings suggest that hippocampal neurogenesis is suppressed by
endogenous thrombin or other PAR-1 agonists under physiological
conditions, whereas under conditions causing neuronal injury,
neurogenesis is enhanced by numerous factors and events.
Although there is no evidence for PAR-1 inactivation following
neuronal injury, the current study showed that PAR-1 inactivation
enhanced NPC proliferation in the dentate gyrus. Future study
should elucidate the role of PAR-1 in neurogenesis triggered
following neuronal injury.
In reactive astrocytes, PAR-1 is involved in thrombin-induced
morphological changes and excess proliferation by activating Gq/
11-coupled signaling followed by inositol triphosphate-dependent
intracellular Ca2þ release and extracellular Ca2þ entry (27).
Further studies demonstrated that thrombin/PAR-1-induced
response in astrocytes is mediated by mitogen-activated protein
kinases including extracellular signal-regulated kinase and Jun N-
terminal kinase (25,28). In addition to the response to astrocytes, it
has been demonstrated that neuronal damage in hemorrhagic
brain injury is caused by thrombin/PAR-1-mediated mitogen-
activated protein kinase pathways (29) and that thrombin-
induced neurotoxicity is caused by activation of extracellular
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Fig. 6. Effect of AP or NCP on proliferative activity of NPC cultures. Cells were cultured for 4 days in the presence of vehicle, AP or NCP at the indicated concentrations. (a) Typical
micrographs of the cells exposed to vehicle, 100 mM AP or 100 mM NCP. Scale bar ¼ 50 mm. (b) Proliferative activity was determined by use of the MTT assay after the exposure to AP
or NCP at the different concentrations indicated. Values are the mean ± S.E. from 4 independent experiments. (c) Proliferative activity was determined by BrdU incorporation after
the exposure to AP or NCP. *P < 0.05, signiﬁcantly different from the value obtained for cultures in the presence of vehicle alone.
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ever, our preliminary data indicating that the exposure of the NPCs
to thrombin for 24 h did not cause signiﬁcant activation of extra-
cellular signal-regulated kinase and Akt (data not shown) allows us
to propose the idea that PAR-1-mediated intracellular signals in the
hippocampal NPCs of the adult are completely different from those
in astrocytes and microglial cells. PAR-1 is known to mediate theRho signaling pathway by in various cells (31). Rho family of small
GTPases including Rho, Rac, and Cdc42 functions as molecular
switches to regulate processes such as cell migration, adhesion,
proliferation, and differentiation (32). Our unpublished data indi-
cate that the RhoA and Cdc42 were expressed in the NPCs used in
the current study and that an exposure of the NPCs to either
thrombin (1 U/mL) or AP (100 mM) for 24 h signiﬁcantly elevated
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Fig. 7. No change in LDH activity released from NPC cultures during treatment
with thrombin or AP. Cells were cultured for 24 h in the presence of vehicle, 1 U/mL
thrombin or 100 mM AP, after which LDH activity in the mediumwas measured. Values
are the mean ± S.E. from 4 independent experiments. N.S., not signiﬁcantly different
from the value obtained for cultures in the presence of vehicle alone.
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Fig. 8. Effect of in vivo treatment with AEBSF on newly-generated cells in the hippocam
i.c.v.), AP (5 mol/2 mL, i.c.v.) or vehicle (2 mL) with BrdU, and then decapitated on day 3 pos
with anti-BrdU antibody or Fluoro-Jade B. (a) Fluorescence micrographs show BrdU-posit
number of BrdU-positive cells in the whole dentate gyrus. Values are expressed as the mean
value obtained for vehicle-treated animals. (c) Typical images of Fluoro-Jade B staining.
treatment (35) were stained for use as a positive control (PC). Scale bar ¼ 100 mm.
M. Tanaka et al. / Journal of Pharmacological Sciences 131 (2016) 162e171170the level of RhoA, but not of Cdc42. These ﬁndings speculate the
possibility that like other cells, the NPC used in the current study
has RhoA signaling as the downstream of PAR-1 signal. However, it
would be still remained as future study to elucidate the mechanism
underlying RhoA-dependent regulation of NPC proliferation.
Dabigatran is widely used to prevent ischemic stroke in non-
valvular atrial ﬁbrillation patients. Recent clinical research
demonstrated the possibility that dabigatran can decrease the
severity of an ischemic stroke even after the stroke has occurred
(33). In stroke induced in adult Sprague Dawley rats by occluding
the middle cerebral artery, intra-arterial infusion of thrombin
during ischemia increases vascular disruption and cellular injury
(34), suggesting that thrombin/PAR-1 is associated with neuronal
damage during ischemia. In this model, argatroban (a direct
thrombin inhibitor) alleviated neurovascular injury (34). As a
conclusion in the previous study, it was proposed that the associ-
ation of thrombin activity with neuronal damage and long-termSF
F AP
AP
AP PC
pal dentate gyrus of the adult mouse. Animals were given either AEBSF (5 mol/2 mL,
t-treatment for preparation of sagittal hippocampal sections, which were then stained
ive cells (newly-generated cells, red) in the dentate gyrus. (b) The graph denotes the
± S.E., calculated from 4 separate experiments. *P < 0.05, signiﬁcantly different from the
Hippocampal slices prepared from the brain on day 2 post-trimethyltin (2.9 mg/kg)
M. Tanaka et al. / Journal of Pharmacological Sciences 131 (2016) 162e171 171cognitive deﬁcit may be clinically signiﬁcant and suggests a role for
early therapy with a thrombin inhibitor for stroke patients. The
current data that dabigatran and AEBSF enhanced hippocampal
neurogenesis through positive regulation of proliferative activity of
the hippocampal NPCs support the proposition that thrombin in-
hibitors would be useful as therapy for brain stroke.
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